Bibliographic Details
| Title: |
Real-World Characteristics and Outcome of Patients Treated With Single-Agent Ibrutinib for Chronic Lymphocytic Leukemia in Spain (IBRORS-LLC Study) |
| Authors: |
Abrisqueta, Pau, Loscertales, Javier, Terol, Maria José, Ramírez Payer, Ángel, Ortiz, Macarena, Pérez, Inmaculada, Cuellar-García, Carolina, Fernández de la Mata, Margarita, Rodríguez, Alicia, Lario, Ana, Delgado, Julio, Godoy, Ana, Arguiñano Pérez, José Mª, Berruezo, Mª José, Oliveira, Ana, Hernández-Rivas, José-Ángel, García Malo, Maria Dolores, Medina, Ángeles, García Martin, Paloma, Osorio, Santiago, Baltasar, Patricia, Fernández-Zarzoso, Miguel, Marco, Fernando, Vidal Manceñido, Mª Jesús, Smucler Simonovich, Alicia, López Rubio, Montserrat, Jarque, Isidro, Suarez, Alexia, Fernández Álvarez, Rubén, Lancharro Anchel, Aima, Ríos, Eduardo, Losada Castillo, María del Carmen, Pérez Persona, Ernesto, García Muñoz, Ricardo, Ramos, Rafael, Yáñez, Lucrecia, Bello, José Luis, Loriente, Cristina, Acha, Daniel, Villanueva, Miguel |
| Source: |
In Clinical Lymphoma, Myeloma and Leukemia December 2021 21(12):e985-e999 |
| Database: |
ScienceDirect |
